A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Add Yahoo as a preferred source to see more of our stories on Google. Unlike typical glaucoma treatments that slow progression, this approach aims to rejuvenate the retinal ganglion cells that die ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

In this excerpt from “We Are As Gods: A Survival God for the Age of Abundance,” authors Peter H. Diamandis and Steven Kotler ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...